DOPAMINE-RECEPTORS IN RAT-BRAIN REGIONS - OPTIMAL CONDITIONS FOR H-3-AGONIST BINDING, PH DEPENDENCY AND LACK OF INHIBITION BY ASCORBIC-ACID

被引:52
作者
BACOPOULOS, NG
机构
[1] DARTMOUTH COLL, HITCHCOCK MED CTR, DARTMOUTH MED SCH, DEPT PHARMACOL, HANOVER, NH 03755 USA
[2] DARTMOUTH COLL, HITCHCOCK MED CTR, DARTMOUTH MED SCH, DEPT PSYCHIAT, HANOVER, NH 03755 USA
关键词
D O I
10.1016/0006-2952(82)90084-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The binding of dopaminergic agonist and antagonist radioligands was investigated in rat brain regions. A 30-min preincubation of homogenates of caudate nucleus or mesolimbic brain regions at 37.degree. induced a several-fold increase in the stereospecific binding of [3H]-dopamine or [3H]apomorphine to the subsequently washed particulate fraction, whereas it induced a slight decrease in [3H]spiroperidol binding. Stereospecific 3H-agonist binding was not observed in brain regions devoid of dopaminergic innervation. Guanosyl nucleotides, EDTA or ethyleneglycol-bis-(.beta.-amino-ethyl ether) N,N''-tetraacetate (EGTA), included in the preincubation buffer, antagonized the stimulation of 3H-agonist binding. The stereospecific binding sites of 3H-agonists were saturable with Kd of 1-2 nM. High-affinity binding was pH dependent, with different pH optima for each radioligand. Several dopamine receptor agonists and antagonists were potent inhibitors of stereospecific [3H]dopamine binding, whereas l-ascorbic acid was inactive at concentrations as high as 1.0 mM. The stereospecific binding of [3H]apomorphine or [3H]spiroperidol was also unaffected by ascorbic acid. The nonspecific (d-butaclamol-insensitive) portion of 3H-agonist binding was weakly inhibited by concentrations of ascorbic acid > 0.01 mM. This effect was also observed in the cerebellum and spinal cord, where none of the 3H-agonist binding was stereospecific. Evidently the portion of 3H-agonist or 3H-antagonist radioligand binding which is related to dopamine receptors is unaffected by ascorbic acid.
引用
收藏
页码:3085 / 3091
页数:7
相关论文
共 29 条
[1]  
BACOPOULOS NG, 1981, J PHARMACOL EXP THER, V219, P708
[2]   ACUTE CHANGES IN THE STATE OF DOPAMINE-RECEPTORS - INVITRO MONITORING WITH 3H-DOPAMINE [J].
BACOPOULOS, NG .
LIFE SCIENCES, 1981, 29 (23) :2407-2414
[3]   CORRELATION BETWEEN TYROSINE-HYDROXYLASE ACTIVITY AND CATECHOLAMINE CONCENTRATION OR TURNOVER IN BRAIN-REGIONS [J].
BACOPOULOS, NG ;
BHATNAGAR, RK .
JOURNAL OF NEUROCHEMISTRY, 1977, 29 (04) :639-643
[4]   HIGH-AFFINITY STEREOSPECIFIC BINDING OF H-3-DOPAMINE IN RAT-BRAIN - INTERACTION WITH ENDOGENOUS DOPAMINE [J].
BACOPOULOS, NG .
BIOCHEMICAL PHARMACOLOGY, 1981, 30 (14) :2037-2040
[5]   DOPAMINE-RECEPTORS IN RAT FRONTAL-CORTEX - PHARMACOLOGICAL PROPERTIES INVIVO AND INVITRO [J].
BACOPOULOS, NG ;
WARE, PL .
LIFE SCIENCES, 1980, 27 (25-2) :2489-2494
[6]  
BURT DR, 1976, MOL PHARMACOL, V12, P800
[7]   DOPAMINE RECEPTOR-BINDING - SPECIFICITY, LOCALIZATION AND REGULATION BY IONS AND GUANYL NUCLEOTIDES [J].
CREESE, I ;
PROSSER, T ;
SNYDER, SH .
LIFE SCIENCES, 1978, 23 (05) :495-499
[8]   H-3-SPIROPERIDOL LABELS SEROTONIN RECEPTORS IN RAT CEREBRAL-CORTEX AND HIPPOCAMPUS [J].
CREESE, I ;
SNYDER, SH .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1978, 49 (02) :201-202
[9]  
CREESE I, 1979, MOL PHARMACOL, V16, P69
[10]   TRANSITIONAL STATES OF THE NEURONAL SEROTONERGIC SITE [J].
FILLION, G ;
FILLION, MP .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1980, 65 (01) :109-112